Thrivent Financial for Lutherans
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 314984
Minneapolis, MN
Position in REGN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$6,521,080
+$539,860 QoQ
Shares Held
8,440
+8.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 79.70379146919431.ToString("F0")%
Shared 0.ToString("F0")%
None 20.296208530805686.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Thrivent Financial for Lutherans holds $270,833,554 across 48 Biotechnology names. REGN ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
1,568,627 | $67,278,411 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
627,699 | $35,458,716 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
75,977 | $33,926,767 | |
| 4 | RPRX |
Royalty Pharma plc
|
499,167 | $23,945,040 | |
| 5 | TECH |
BIO-TECHNE Corp
|
302,934 | $15,831,330 | |
| 6 | ARGX |
Argenx SE
|
12,682 | $9,261,030 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,470 | $6,772,908 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
8,440 | $6,521,080 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,521,080 | 8,440 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $5,981,220 | 7,749 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $4,236,704 | 7,535 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,994,325 | 9,513 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $87,707,666 | 138,290 | Shares | Defined | 2025-08-26 | |
| 2024-12-31 | $89,179,441 | 125,194 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $9,587,308 | 9,120 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $8,212,748 | 7,814 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,551,696 | 7,846 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,782,021 | 9,999 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,167,567 | 13,570 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $64,348,848 | 89,555 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $93,117,395 | 113,327 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $119,852,475 | 166,118 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $109,065,342 | 158,325 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $72,953,125 | 123,413 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $14,390,245 | 20,604 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $33,460,455 | 52,984 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $33,284,294 | 54,999 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $30,830,849 | 55,199 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $18,288,280 | 38,653 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $28,055,163 | 58,072 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $24,663,347 | 44,059 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $28,122,873 | 45,094 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,777,863 | 3,641 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||